Stock data

優盛 (4121)

優盛 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$328.61M, up 9.2% from a year earlier. EPS over the last four quarters totals -NT$0.50.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 優盛 in Insightr